AU2025206411A1 — Methods of treating TTR amyloidosis using AG10

USPTO Abstract

#$%^&*AU2025206411A120250807.pdf##### ABSTRACT OF THE DISCLOSURE Described herein are methods for treating transthyretin (TTR) amyloidosis in a subject. The methods include specific dosing regimens that have great efficacy in treating the subjects and that are well tolerated in subjects. ABSTRACT OF THE DISCLOSURE Described herein are methods for treating transthyretin (TTR) amyloidosis in a subject. The methods include specific dosing regimens that have great efficacy in treating the subjects and that are well tolerated in subjects. 20 25 20 64 11 22 J ul 2 02 5 J u l 2 0 2 5 A B S T R A C T O F T H E D I S C L O S U R E D e s c r i b e d h e r e i n a r e m e t h o d s f o r t r e a t i n g t r a n s t h y r e t i n ( T T R ) a m y l o i d o s i s i n a s u b j e c t . T h e m e t h o d s i n c l u d e s p e c i f i c d o s i n g r e g i m e n s t h a t h a v e g r e a t e f f i c a c y i n t r e a t i n g t h e s u b j e c t s a n d t h a t a r e w e l l t o l e r a t e d i n s u b j e c t s . 2 0 2 5 2 0 6 4 1 1 2 2